PathoNext

PathoNext is a Germany-based molecular diagnostics and genomics company focused on next-generation sequencing, bioinformatics, and molecular pathology services. The company provides NGS-based analysis workflows including DNA and RNA extraction, library preparation, sequencing, data analysis, and customized reporting for research and diagnostic applications. Its offerings include proprietary and commercial gene panels, contract sequencing services such as whole-genome, whole-exome, metagenome, and RNA sequencing, and support for precision medicine use cases in oncology. PathoNext has also served as a local laboratory partner for Agendia's MammaPrint and BluePrint breast cancer assays in Germany. The company appears to operate as part of the Genolytic group in Leipzig.